Form 8.5 (EPT/RI) - Tesco plc FORM 8.5 (EPT/RI)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
69
Form 8.5 (EPT/RI) - Tesco plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

1.         KEY INFORMATION

(a) Name of exempt principal trader:   Investec Bank plc  
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree   Tesco plc
(c) Name of the party to the offer with which exempt principal trader is connected:     Investec are Advisor & Broker to Booker Group plc  
(d) Date dealing undertaken:    3rd February2017  
(e) Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? Yes

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received (pence)   Lowest price per unit paid/received (pence)
  Ordinary Voting Shares     Purchases   340,678   197.793   197.1175
  Ordinary Voting Shares     Sales   341,676   198.025   197.05

(b)        Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"
  None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None
  Date of disclosure: 6th February 2017
  Contact name:   Robert Letson
  Telephone number:   020 7597 5690
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading